XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Operating Activities    
Net Loss $ (98,007) $ (59,203)
Adjustments to reconcile net loss to net cash used in operating activities:    
Impairment loss 24,749 0
Loss on disposal of assets 499 5,137
(Gain) on forgiveness of SBA Loans 0 (641)
Stock-based compensation 17,419 9,874
Depreciation and amortization 7,887 5,128
Amortization of marketable securities premium 2,723 5,029
Other noncash (income) expense 877 89
Changes in operating assets and liabilities:    
Accounts receivable 502 (257)
Inventories (2,004) (259)
Prepaid expenses and other current assets, deposits and other assets (10,893) (12,897)
Accounts payable, accrued expenses and long-term liabilities 3,635 (271)
Net cash used in operating activities (52,613) (48,271)
Investing Activities    
Acquisitions of property, plant and equipment (75,775) (56,770)
Acquisition of patent portfolio (10) 0
Proceeds from sale and maturity of marketable securities 299,581 79,574
Purchase of patents and license 0 (9,170)
Purchase of marketable securities (130,402) (424,992)
Net cash provided by (used in) investing activities 93,394 (411,358)
Financing Activities    
Proceeds from issuance of long-term debt 0 68,995
Debt and equity offering costs (10,993) (34,955)
Proceeds from issuance of common stock and common stock warrants 150,000 489,373
Proceeds from exercise of warrants 3 1,121
Net settlement of common stock under stock plans (286) (7,041)
Payment of loans payable - other (150) (154)
Payment of finance lease liabilities (12) (15)
Net cash provided by financing activities 138,562 517,324
Net increase in cash and cash equivalents 179,343 57,695
Cash, cash equivalents and restricted cash at beginning of period 136,033 78,338
Cash, cash equivalents and restricted cash at end of period 315,376 136,033
Schedule of cash, cash equivalents and restricted cash    
Cash and cash equivalents 237,125 40,833
Restricted cash (current) 1,032 25,032
Long-term restricted cash 77,219 70,168
Total cash, cash equivalents and restricted cash 315,376 136,033
Supplemental disclosures of cash and non-cash investing and financing transactions    
Cash paid for interest, net of amounts capitalized 522 (806)
Non-cash purchase of property, plant and equipment 13,837 20,287
Right-of-use asset purchased with financing leases 0 245
Right-of-use asset purchased with operating lease 0 1,611
Non-cash interest capitalized to construction in progress $ 0 $ 1,125